These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2451581)

  • 21. Counterstained enhancement of TaqI resistant sites after distamycin A/diamidinophenylindole treatment.
    Conte RA; Verma RS
    Histochemistry; 1994 Dec; 102(6):433-5. PubMed ID: 7535295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variability of DA/DAPI and C heterochromatic regions: a population study.
    Tofanelli S; Stanyon R; Agostini M; Franceschi MG; Paoli G
    Hum Biol; 1993 Aug; 65(4):635-46. PubMed ID: 7802857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for associations of DA-DAPI fluorescent regions in a subset of peripheral blood lymphocyte nuclei in man (Homo sapiens L.) and domestic pig (Sus scrofa dom. L.).
    Schellander K; Mayr B; Kalat M; Radaszkiewicz T; Schleger W
    Haematologica; 1984; 69(3):249-56. PubMed ID: 6432637
    [No Abstract]   [Full Text] [Related]  

  • 24. Deciphering the fluorescent variability of human genomic heterochromatin by DA/DAPI technique.
    Verma RS; Conte RA; Luke S; Sindwani V; Macera MJ
    Clin Genet; 1992 Nov; 42(5):267-70. PubMed ID: 1283119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Counterstain-enhanced chromosome banding.
    Schweizer D
    Hum Genet; 1981; 57(1):1-14. PubMed ID: 6167505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late separating D/D fusions in subjects with "balanced" translocation.
    Méhes K; Bajnóczky K; Bühler EM; Kosztolanyi G
    Ann Genet; 1991; 34(1):19-21. PubMed ID: 1952785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential fluorescent staining of porcine heterochromatin by chromomycin A3/distamycin A/DAPI and D 287/170.
    Schnedl W; Abraham R; Förster M; Schweizer D
    Cytogenet Cell Genet; 1981; 31(4):249-53. PubMed ID: 7341070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterochromatin in the chromosomes of the gorilla: characterization with distamycin A/DAPI, D287/170, chromomycin A3, quinacrine, and 5-azacytidine.
    Schmid M; Haaf T; Ott G; Scheres JM; Wensing JA
    Cytogenet Cell Genet; 1986; 41(2):71-82. PubMed ID: 2420535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-banding with specific fluorescent DNA-ligands: a new approach to constitutive heterochromatin heterogeneity.
    Bella JL; Gosálvez J
    Biotech Histochem; 1991; 1(1):44-52. PubMed ID: 1716159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for specificity of the DA/DAPI technique.
    Merkx GF; Hopman AH; Akkermans-Scholten AC; Smeets DF
    Cytogenet Cell Genet; 1990; 54(1-2):62-4. PubMed ID: 1701116
    [No Abstract]   [Full Text] [Related]  

  • 31. Expression of heterochromatin by restriction endonuclease treatment and distamycin A/DAPI staining of Indian muntjac (Muntiacus muntjak) chromosomes.
    Babu A; Verma RS
    Cytogenet Cell Genet; 1986; 41(2):96-100. PubMed ID: 2420537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Giemsa banding patterns of 13/14, 21/21 translocations, Philadelphia chromosome and trisomy 18.
    Taysi K; Hatiboğlu N; Halicioglu C; Say B
    Turk J Pediatr; 1972 Oct; 14(4):141-5. PubMed ID: 16295083
    [No Abstract]   [Full Text] [Related]  

  • 33. Modification of DAPI banding on human chromosomes by prestaining with a DNA-binding oligopeptide antibiotic, distamycin A.
    Schweizer D; Ambros P; Andrle M
    Exp Cell Res; 1978 Feb; 111(2):327-32. PubMed ID: 75107
    [No Abstract]   [Full Text] [Related]  

  • 34. Reassessment of presumed Y/22 and Y/15 translocations in man using a new technique.
    Spowart G
    Cytogenet Cell Genet; 1979; 23(1-2):90-4. PubMed ID: 83932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Filamentous appearance of DA-DAPI positive heterochromatin in leukemic cells.
    Gruber K; Linkesch W; Mayr B
    Haematologica; 1988; 73(2):105-9. PubMed ID: 2457541
    [No Abstract]   [Full Text] [Related]  

  • 36. Molecular cytogenetic and clinical studies of 42 patients with marker chromosomes.
    Callen DF; Eyre H; Yip MY; Freemantle J; Haan EA
    Am J Med Genet; 1992 Jul; 43(4):709-15. PubMed ID: 1377870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific fluorescent bands on chromosomes produced by acridine orange after prestaining with base specific non-fluorescent DNA ligands.
    Lin CC; Jorgenson KF; van de Sande JH
    Chromosoma; 1980; 79(3):271-86. PubMed ID: 6156809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Value of silver staining technics for the study of acrocentric ring chromosomes and supernumerary microchromosomes].
    Teyssier M; Moreau N
    C R Seances Soc Biol Fil; 1984; 178(3):251-6. PubMed ID: 6208982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NSG banding of sequentially QFQ and RFA banded human acrocentric chromosomes.
    Ved Brat S; Verma RS; Dosik H
    Stain Technol; 1980 Mar; 55(2):77-80. PubMed ID: 6157229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined use of cytogenetic analysis and FISH for the identification of two antenatal de novo markers as Robertsonian translocations involving the p arms.
    Pierluigi M; Battaglia P; Perfumo C; Baroncini A; Bricarelli FD
    Ann Genet; 1997; 40(2):99-103. PubMed ID: 9259956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.